Paclitaxel Injectable 100mg - Shelf Life: 24 Months

Paclitaxel Protein-Bound Particles for Injectable Suspension (albumin-bound) is a microtubule inhibitor indicated for the treatment of:

Metastatic breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.

Locally advanced or metastatic non-small cell lung cancer (NSCLC) as first-line treatment in combination with carboplatin in patients who are not candidates for curative surgery or radiation therapy.

Metastatic adenocarcinoma of the pancreas as first-line treatment in combination with gemcitabine.